Blower, Philip J. and Clark, Katherine and Link, Eva M. (1997) Radioiodinated methylene blue for melanoma targeting: Chemical characterisation and tumour selectivity of labelled components. Nuclear Medicine and Biology, 24 (4). pp. 305-310. ISSN 0883-2897. (doi:https://doi.org/10.1016/S0969-8051(97)00040-1) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided)
|The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided. (Contact us about this Publication)|
Radioiodinated methylene blue contains a mixture of components showing selective uptake in human pigmented melanoma, and it has potential for imaging and therapy. Nuclear magnetic resonance and mass spectroscopic studies show that the majority of the radioactivity (85%) is in the form of monoiodinated methylene blue, 4-iodo-3-methylamino-7-dimethylaminophenaza thionium chloride. The amino group ortho to iodine has become demethylated to a mono-methylamino group, The remainder (15%) of the mixture is the doubly labelled 4,5-diiodo-3,7-bis(methylamino) phenazathionium chloride. The separated components show similar tumour selectivity in athymic mice bearing human pigmented melanomas. (C) 1997 Elsevier Science Inc.
|Depositing User:||T. Nasir|
|Date Deposited:||29 Oct 2009 05:56 UTC|
|Last Modified:||11 Jun 2014 13:53 UTC|
|Resource URI:||https://kar.kent.ac.uk/id/eprint/18297 (The current URI for this page, for reference purposes)|